(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

WELLESLEY PHARMACEUTICALS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

WELLESLEY PHARMACEUTICALS

ST13

US500000086821139

Class

5

Filing

86821139

Registration

6185393

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

80

Latest update

10/28/2025

Trademark type

Word

Nice classes

5

Filing date

11/16/2015

Registration date

10/27/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/27/2020

Last transaction

10/28/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/21/2016

First use in commerce

03/21/2016

Drawing code

4

Owner type

16

Owner location

Newtown, PA

Examiner

GAYNOR,BARBARA ANNE

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Wellesley Pharmaceuticals, LLC

Representatives

Michael Ye MORRIS, MANNING & MARTIN, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for reducing frequency of urination

Publications

History of USPTO decisions and trademark events.

80 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/27/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

10/27/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/22/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/21/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/16/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/16/2020

ALIE

ASSIGNED TO LIE

09/14/2020

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

09/09/2020

GNS1

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

09/03/2020

GNCF

CONTINUATION OF FINAL REFUSAL E-MAILED

09/03/2020

CNCF

SU - ACTION CONTINUING FINAL - WRITTEN

09/03/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/21/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/21/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/21/2020

ALIE

ASSIGNED TO LIE

08/19/2020

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

08/10/2020

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

02/24/2020

GNFR

FINAL REFUSAL E-MAILED

02/24/2020

CNFR

SU - FINAL REFUSAL - WRITTEN

02/24/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/12/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/12/2020

ALIE

ASSIGNED TO LIE

02/11/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/05/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/08/2019

GNRT

NON-FINAL ACTION E-MAILED

08/08/2019

CNRT

SU - NON-FINAL ACTION - WRITTEN

08/08/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/30/2019

IUAF

USE AMENDMENT FILED

07/26/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/26/2019

EISU

TEAS STATEMENT OF USE RECEIVED

07/26/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/11/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/06/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/05/2019

EX5G

SOU EXTENSION 5 GRANTED

02/04/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/01/2019

EXT5

SOU EXTENSION 5 FILED

02/01/2019

EEXT

SOU TEAS EXTENSION RECEIVED

02/01/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/21/2018

EX4G

SOU EXTENSION 4 GRANTED

07/19/2018

EXT4

SOU EXTENSION 4 FILED

07/19/2018

EEXT

SOU TEAS EXTENSION RECEIVED

07/19/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/12/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/12/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/15/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/12/2018

EX3G

SOU EXTENSION 3 GRANTED

01/10/2018

EXT3

SOU EXTENSION 3 FILED

01/10/2018

EEXT

SOU TEAS EXTENSION RECEIVED

01/10/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/07/2017

EX2G

SOU EXTENSION 2 GRANTED

09/06/2017

IROA

RESPONSE TO ITU OFFICE ACTION ENTERED

08/07/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/07/2017

INCE

ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST

08/07/2017

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/21/2017

EXT2

SOU EXTENSION 2 FILED

07/11/2017

EEXT

SOU TEAS EXTENSION RECEIVED

07/11/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/31/2017

EX1G

SOU EXTENSION 1 GRANTED

01/27/2017

EXT1

SOU EXTENSION 1 FILED

01/27/2017

EEXT

SOU TEAS EXTENSION RECEIVED

01/27/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/02/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/07/2016

PUBO

PUBLISHED FOR OPPOSITION

06/07/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/18/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/30/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/27/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

04/27/2016

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/27/2016

GNEA

EXAMINERS AMENDMENT E-MAILED

04/27/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/27/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/26/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/26/2016

ALIE

ASSIGNED TO LIE

04/14/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/29/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/08/2016

GNRT

NON-FINAL ACTION E-MAILED

03/08/2016

CNRT

NON-FINAL ACTION WRITTEN

03/08/2016

DOCK

ASSIGNED TO EXAMINER

03/05/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/19/2015

NWAP

NEW APPLICATION ENTERED

11/19/2015

Continuous trademark protection

Get notified about every new filing that threatens WELLESLEY PHARMACEUTICALS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.